Loading…
ASC Payment Transparency Act of 2019
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
51pct
1d open
vs 9,062 other HR bills in the 116th — cohort avg 39d
Ambulatory Surgical Center Payment Transparency Act of 2019 or ASC Payment Transparency Act of 2019 This bill requires the Centers for Medicare & Medicaid Services to specify the criteria used to exclude certain procedures from the list of covered surgical procedures that may be performed in an ambulatory surgical center under Medicare. The bill also requires the expert outside advisory panel that reviews the Medicare prospective payment system for hospital outpatient department services to include at least one ambulatory surgical center representative.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2020 · first_quarter · Health Issues
general issues related to drug pricing; issues related to cosmetic regulations; issues related to insulin pricing;issues related to s.102 "Prescription Drug Price Relief Act of 2019"; issues related to International Reference pricing; issues related to OTC Monograph Reform in CARES Act; issues related to HSA/FSA in CARES Act; issues related to Vaccine provisions in CARES Act; issues related to prescription to over-the-counter switch; issues related to Drug Importation;issues related to H.R. 3 "Lower Drug Costs Now Act of 2019"; issues related to S. 2740 "Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019"; issues related to influenza vaccines; issues related to the Executive Order on Flu; issues related to Coronavirus COVID-19; issues related to Copay Accumulators; issues related to RSV access; issues related to HR.3433- Over the counter Monograph Safety, Innovation and Reform Act 2019; issues related to S.2158- Newborn Screening Saves Lives; and issues related to CMMI- Insulin Demo.
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $1,750,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · first_quarter · Health Issues
H.R.748: Coronavirus Aid, Relief, and Economic Security Act or the CARES Act as it relates to H.R.3433: Over-the-Counter Monograph Safety, Innovation and Reform Act, and H.R1922: Restoring Access to Medication Act of 2019. Draft legislation on cosmetics regulation at FDA. Issues related to RX/OTC switch. Education around potential therapies and vaccines for COVID-19.
Client expense: Not reported · Firm income: $50,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, SENATE
2020 · first_quarter · Health Issues
H.R.748: Coronavirus Aid, Relief, and Economic Security Act or the CARES Act as it relates to H.R.3433: Over-the-Counter Monograph Safety, Innovation and Reform Act, and H.R.1922: Restoring Access to Medication Act of 2019. Proposed legislation around FDA cosmetics reform. Issues related to oral health.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2019 · fourth_quarter · Health Issues
H.R.3433: Over-the-Counter Monograph Safety, Innovation and Reform Act. Draft legislation on cosmetics regulation at FDA. Issues related to RX/OTC switch
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Health Issues
H.R.3433: Over-the-Counter Monograph Safety, Innovation and Reform Act. Proposed legislation around FDA cosmetics reform.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Health Issues
H.R.3433: Over-the-Counter Monograph Safety, Innovation and Reform Act. Discussion draft on FDA cosmetics regulatory reform.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Health Issues
H.R.3433: Over-the-Counter Monograph Safety, Innovation and Reform Act. Draft legislation on cosmetics regulation at FDA. Issues related to RX/OTC switch Issues around influenza vaccines.
Client expense: Not reported · Firm income: $50,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Health Issues
H.R.3433: Over-the-Counter Monograph Safety, Innovation and Reform Act. Proposed legislation around FDA cosmetics reform.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Health Issues
H.R.3433: Over-the-Counter Monograph Safety, Innovation and Reform Act. Discussion draft on FDA cosmetics regulatory reform.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE